|
C18ORF45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.357800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.131000E-01 |
| Normal-vs-Stage2 |
4.487400E-01 |
| Normal-vs-Stage3 |
7.989600E-01 |
| Normal-vs-Stage4 |
3.164100E-02 |
| Stage1-vs-Stage2 |
5.623400E-01 |
| Stage1-vs-Stage3 |
9.913200E-01 |
| Stage1-vs-Stage4 |
4.643900E-02 |
| Stage2-vs-Stage3 |
6.698600E-01 |
| Stage2-vs-Stage4 |
3.741800E-01 |
| Stage3-vs-Stage4 |
1.304170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.186600E-01 |
| Normal-vs-AfricanAmerican |
8.801000E-01 |
| Normal-vs-Asian |
6.593400E-01 |
| Caucasian-vs-AfricanAmerican |
9.289200E-01 |
| Caucasian-vs-Asian |
7.448000E-01 |
| AfricanAmerican-vs-Asian |
9.550200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.741000E-01 |
| Normal-vs-Female |
3.758400E-01 |
| Male-vs-Female |
7.234400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.920400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.312810E-01 |
| Normal-vs-Age(61-80Yrs) |
4.842400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.025000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.692100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.615800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.397400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.047400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.714000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.930000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.213600E-01 |
| Classical-VS-Follicular |
6.339100E-03 |
| Classical-VS-Other |
2.446400E-01 |
| Classical-VS-Normal |
7.043400E-01 |
| Tall-VS-Follicular |
3.782600E-01 |
| Tall-VS-Other |
4.796000E-01 |
| Tall-VS-Normal |
5.387600E-01 |
| Follicular-VS-Other |
7.985800E-01 |
| Follicular-VS-Normal |
2.316300E-02 |
| Other-VS-Normal |
3.060400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.372000E-01 |
| Normal-vs-N1 |
8.501700E-02 |
| N0-vs-N1 |
2.716600E-01 |
|
|
